[ET Net News Agency, 26 March 2026] BOCI raised the target price for Wuxi Bio (02269) to HKD37 from HKD31 and maintained the "buy" rating.
The research house said it forecasts WuXi Bio to deliver revenue growth of 16%/15% YoY in FY26/FY27. (rc)
The research house said it forecasts WuXi Bio to deliver revenue growth of 16%/15% YoY in FY26/FY27. (rc)